Abstract

A Randomized Trial of a Group-Based Integrative Medicine Approach Compared to Waitlist Control on Irritable Bowel Syndrome Symptoms in Adults

McDonald E1, Teets R2, Ortiz C1, Gilchrist C1, Waltermaurer E2, Perez E1, Kligler B3. Explore (NY). 2018 Jul 20. pii: S1550-8307(18)30010-7. doi: 10.1016/j.explore.2018.04.008. [Epub ahead of print]
 
     

Author information

1 Mount Sinai Beth Israel, Department of Integrative Medicine, 245 Fifth Avenue 2nd Floor, New York, NY 10016, USA.

2 Department of Family Medicine and Community Health, Icahn School of Medicine at Mount Sinai and Institute for Family Health, 16 east 16th street, New York, NY 10003, USA.

3 Department of Family Medicine and Community Health, Icahn School of Medicine at Mount Sinai and Institute for Family Health, 16 east 16th street, New York, NY 10003, USA. Electronic address: Benjamin.Kligler@mountsinai.org.

Abstract

INTRODUCTION: Irritable bowel syndrome (IBS) is a chronic debilitating functional gastrointestinal disorder that affects a large proportion of the general population. Dietary and mind-body approaches have shown some effectiveness in reducing IBS symptoms.

OBJECTIVES: The purpose of this project was to test the feasibility of a low cost, group-oriented integrative medicine approach to IBS, and to explore whether such an approach improves participant outcomes.

METHODS: This was a randomized-controlled trial involving a 4-week group-oriented treatment intervention combining dietary intervention and mind-body therapies followed by 8-weeks of telephonic health coaching. Differences between the intervention and control groups on IBS-specific measures were examined at baseline, 4, 8, and 12-week.

RESULTS: Fifty-two participants completed the study, 30 in the control group and 22 in the intervention group. On the IBS Symptom Severity Score, at 4 weeks the intervention group showed statistically significant improvement compared to the control group (p < .02), which was sustained at the 8 and 12-week data points as well, with the proportion of the intervention group experiencing moderate to severe symptoms decreasing from 81.3% at baseline to 45% at week 4 and 54.5% at week 12. A statistically significant improvement was also seen on the CES-D measure of depression between baseline and week 12 in the intervention group compared to controls. On the IBS Quality of Life measure we did not observe a statistically significant difference between the groups.

CONCLUSIONS: This low-cost, group-oriented intervention approach offers a strategy to address the challenge of access to this type of integrative approach for patients of low socioeconomic status or limited means.

© Copyright 2013-2019 GI Health Foundation. All rights reserved.
This site is maintained as an educational resource for US healthcare providers only. Use of this website is governed by the GIHF terms of use and privacy statement.